Cairo, Egypt: Siemens Healthineers, a global leader in medical technology, announced its participation in Africa Health Excon 2025, held under the patronage of His Excellency President Abdel Fattah El-Sisi from June 24 to 27 at the Egypt International Exhibition Center (EIEC). Professor Dr. Khaled Abdel Ghaffar, Deputy Prime Minister and Minister of Health and Population, accompanied by Professor Dr. Hisham Steit, Chairman of the Unified Procurement Authority, visited the Siemens Healthineers Egypt booth, where they were briefed on the company’s latest solutions and AI-powered technologies. The company showcased an advanced portfolio of healthcare solutions as part of its commitment to supporting the digital transformation of the healthcare sector in Egypt and the region.

Siemens Healthineers is present at this year's edition with two dedicated pavilions within the exhibition. The main pavilion highlights advanced diagnostic and interventional radiology solutions, while the second pavilion focuses on next-generation laboratory diagnostic technologies. During the exhibition, the company unveiled a range of pioneering innovations, including the latest MAGNETOM Flow Elite, a 1.5 Tesla, 70 cm diameter MRI that does not require helium refilling, enhancing operational efficiency and high-quality examination accuracy. It also unveiled the NAEOTOM Alpha.Prime, the world's first photon-counting CT scanner, designed to deliver ultra-high-resolution imaging and powered by artificial intelligence to accelerate workflow and support clinical decision-making. The company also introduced the SOMATOM On.site, a mobile CT scanner that enables accurate examinations in critical care settings such as intensive care units or ambulances, thanks to its innovative telescopic design and advanced technologies.

The company is also showcasing a comprehensive range of radiology solutions, such as the MOBILETT Elara Max mobile x-ray, ACUSON Sequoia and ACUSON Juniper ultrasound machines, along with Symbia Pro.specta and Biograph Trinion piezotrons. The laboratory diagnostics pavilion highlights innovative solutions such as the Atellica CN-3000 coagulation analyzer, Atellica HEMA 580 and Atellica HEMA 530 hematology analyzers, the Hematek 3000 sedimentation system, and Atellica CI chemistry analyzers, highlighting the diagnostic integration offered by Siemens Healthineers. These advanced solutions play a pivotal role in supporting the development of Egypt's healthcare system by enabling early detection, improving treatment outcomes, and expanding access to high-quality healthcare services across the country.

Commenting on the occasion, Eng. Amr Kandil, CEO of Siemens Healthineers Egypt , said: “Our annual participation in Health Africa reflects our unwavering commitment to supporting the effective transformation of Egypt’s healthcare sector through innovation, strategic partnerships, and investment in capacity building. This year, we proudly announce the launch of the first center of its kind in the Middle East for the development and modernization of radiology equipment in Egypt, in partnership with the Ministry of Health and Population and the Unified Procurement Authority. This is a qualitative step towards enhancing the quality and efficiency of healthcare services by rehabilitating equipment according to the highest international standards and at competitive prices.” He added: “We also continue to invest in human capital by expanding the scope of the Siemens Healthineers Academy in Egypt, which is about to transform into an educational training and development center serving Africa and the Middle East. We believe that developing medical personnel is the cornerstone of building a more sustainable healthcare system that is prepared for the requirements of the future.”

For his part, Diaa El-Shenawy, Head of Sales for Government and NGO Sectors and Head of Government Affairs, commented: “The Africa Health exhibition provides opportunities to enhance collaboration in the healthcare sector and support the country’s priorities in developing this sector.” He added: “At Siemens Healthineers, we are committed to providing solutions tailored to meet market demands and the needs of the government sector, by providing advanced medical technology that addresses local challenges and contributes to enhancing the efficiency and sustainability of healthcare services.”

Siemens Healthineers continues to support presidential initiatives, such as the Women's Health Initiative and the Early Detection and Treatment of Cancer Initiative. The company is also contributing to the state's initiative to establish a network of specialized stroke centers, providing solutions such as the Artis Icono Pro device, which was installed at the Ain Shams University Stroke Center to accelerate diagnosis and therapeutic intervention.

Following its acquisition of Varian, Siemens Healthineers expanded its solutions portfolio to include advanced technologies in oncology and precision medicine, enhancing its ability to offer an integrated suite of diagnostic and therapeutic solutions tailored to the needs of Egypt's healthcare sector.

These efforts embody Siemens Healthineers' commitment to enhancing the sustainability of Egypt's healthcare system through technology, effective partnerships, capacity building, and expanding access to high-quality healthcare.

About Siemens Healthineers

Siemens Healthineers (listed in Frankfurt, Germany , SHL ) is a pioneer in discoveries for sustainable healthcare for everyone. The company is a global provider of healthcare equipment, solutions, and services, with operations in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to and developing healthcare in underserved communities worldwide and combating the most serious diseases. The company's activities lie primarily in the areas of imaging, diagnostics, cancer treatment, cost-effective non-invasive therapies, as well as digital technology and artificial intelligence. Siemens Healthineers has approximately 71,000 employees worldwide and generated revenue of approximately €21.7 billion in fiscal year 2023, which ended September 30, 2023.

-I finish-

#Corporate Data

Disclaimer for the content of press releases
The content of these press releases is provided by a third-party provider. We do not assume any responsibility for, nor do we have any control over, such content. This content is provided on an 'as is' and 'as available' basis and has not been edited in any way. Neither we nor our affiliates are responsible for the accuracy, endorsement, or completeness of the opinions, views, information, or materials contained in this content.
Press releases are provided for informational purposes only; the content does not imply legal, investment, or tax advice or any opinion regarding the suitability, value, or profitability of any particular portfolio or investment strategy. We, or our affiliates, will not be liable for any errors or inaccuracies in the content, or for any actions you take based on such content. You expressly agree and acknowledge that you bear full responsibility for the use of the information contained in these press releases.
To the extent permitted by applicable law, Refinitiv, its parent, subsidiaries, affiliates, and their respective shareholders, directors, officers, employees, agents, advertisers, content providers, and licensors (collectively, the “Refinitiv Parties”) will not be liable (either jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive, or exemplary damages; This includes, but is not limited to: lost profits, lost savings or revenue, whether caused by negligence, tort, contract or other liability theories, even if the Refinitiv Parties have been advised of the possibility of any such damages and losses or had actually anticipated their occurrence.